Home › Cases › The Same Diagnosis, Three Different Treatments
DIC
The Same Diagnosis, Three Different Treatments
6 questions
Question 1 · Obstetric
Correct answer: Delivery of placental products is the treatment of the cause, and TXA 1g IV is indicated in obstetric DIC
Why
Obstetric DIC: delivery of placental products treats the cause, and TXA 1g IV over 10 minutes is indicated.
- Retained products keep driving the consumption, so haematological support alone will not resolve it
- This is the one setting where TXA is clearly indicated in DIC — contrast with sepsis and APML, where it is avoided
- Obstetric DIC needs obstetrics, haematology and critical care together
- Heparin has no role here
Key point
Obstetric DIC is the TXA exception. Deliver the products and give the tranexamic acid.
Question 2 · APML
Correct answer: ATRA — all-trans retinoic acid — urgently, as it reduces DIC-related mortality
Why
APML: ATRA urgently — it reduces DIC-related mortality.
- APML is the classic malignancy-associated DIC, and the coagulopathy is what kills these patients in the first days, before the leukaemia does
- ATRA is started on clinical suspicion, before cytogenetic confirmation, precisely because the delay costs lives
- Avoid TXA in APML-related DIC
- APML-related DIC needs haematology and oncology the same day
- Product support continues alongside, but ATRA is the intervention that changes the outcome
Key point
ATRA urgently in APML — it is what reduces the mortality. And no TXA.
Question 3 · Trauma
Correct answer: Haemorrhage control and damage-control resuscitation
Why
Trauma: haemorrhage control and damage-control resuscitation.
- The bleeding is both the cause and the consequence, so stopping it is the treatment — the same logic as post-operative haemorrhage
- Damage-control surgery — abbreviated surgery to control haemorrhage with definitive repair deferred — applies here
- Waiting to normalise the clotting before operating is exactly backwards: the coagulopathy will not correct while the patient is bleeding
- The lethal triad — hypothermia, acidosis, coagulopathy — applies directly
Key point
You cannot correct the clotting while they are still bleeding. Control the haemorrhage first.
Question 4 · The Common Thread
Correct answer: Treating the underlying cause is the single most important step; haematological support is a bridge
Why
Treat the underlying cause. All haematological support is a bridge. It is the pathway's central statement.
- Sepsis → antibiotics. Obstetric → deliver the products. APML → ATRA. Trauma → haemorrhage control.
- The product replacement thresholds *are* broadly common — FFP 15ml/kg, cryoprecipitate if fibrinogen below 1.5, platelets below 50 with bleeding or below 20 without — but they support rather than treat
- TXA differs completely by cause: indicated in obstetric, avoided in sepsis and APML
- This is why the first question in DIC is always "what is driving it?"
Key point
Four causes, four different treatments, one principle. Support is a bridge to treating the cause.
Question 5 · Not Bleeding
Correct answer: No — the threshold without bleeding is below 20 × 10⁹/L
Why
Platelet transfusion if below 50 × 10⁹/L WITH active bleeding, or below 20 if not bleeding. At 34 without bleeding, she is between the two thresholds.
- The distinction matters because transfusing platelets in a consumptive thrombotic process is not free — the products are consumed, and there is a theoretical concern about fuelling thrombosis
- A score alone does not trigger transfusion; the clinical state does
- Aiming for a normal platelet count in active DIC is neither achievable nor the goal
- Continue treating the cause and monitor six-hourly
Key point
Under 50 with bleeding; under 20 without. The number alone does not decide it.
Question 6 · Who Decides
Correct answer: Haematology, urgently — and the cause-specific team alongside
Why
All patients with overt DIC require urgent haematology input.
- Plus the cause-specific team: oncology the same day for APML; obstetrics and critical care for obstetric DIC; surgery for trauma
- Haematology guide product selection, interpret a moving coagulation picture, and advise on the genuinely difficult decisions such as whether heparin has a place
- Critical care will very often be involved and is essential in the unstable patient, but they do not replace haematology
- Treating the cause is necessary and not sufficient — the coagulopathy needs managing in parallel
Key point
Overt DIC always means haematology, urgently. Plus whichever team owns the cause.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.